Three Lakes Partners Asset Manager Profile - aVenture Research
Three Lakes Partners is a venture philanthropy focused on investing in idiopathic pulmonary fibrosis (IPF) treatments within the healthcare sector. Based in Northbrook, Illinois, the firm partners with innovators globally to improve quality of life and accelerate solutions for those affected by pulmonary fibrosis. Their investments typically target Series B rounds.
The organization aims to drive public awareness and advance research in the field of pulmonary fibrosis. Three Lakes Partners' portfolio includes Unity Biotechnology, which has raised $35 million. Established in 2016, the firm combines philanthropic goals with venture capital strategies to support breakthrough treatments and technologies in the fight against IPF.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.